The Enterprise Value as of September 2024 (TTM) for Vericel Corporation (VCEL) is 2.29B

According to Vericel Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 2.29B. This represents a change of 13.16% compared to the average of 2.03B of the last 4 quarters.

Vericel Corporation (VCEL) Historical Enterprise Value (quarterly & annually)

How has VCEL Enterprise Value performed in the past?

The mean historical Enterprise Value of Vericel Corporation over the last ten years is 789.00M. The current 2.29B Enterprise Value has changed 28.96% with respect to the historical average. Over the past ten years (40 quarters), VCEL's Enterprise Value was at its highest in in the March 2024 quarter at 2.57B. The Enterprise Value was at its lowest in in the September 2014 quarter at -8146950.00.

Vericel Corporation (VCEL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vericel Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vericel Corporation (VCEL) Average Enterprise Value

How has VCEL Enterprise Value performed in the past?

The current Enterprise Value of Vericel Corporation (VCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vericel Corporation (VCEL) Enterprise Value vs. Peers

How is VCEL’s Enterprise Value compared to its peers?

Vericel Corporation’s Enterprise Value is greater than CollPlant Biotechnologies Ltd. (38.81M), greater than Keros Therapeutics, Inc. (1.70B), less than Merus N.V. (2.75B), greater than Century Therapeutics, Inc. (154.70M), greater than Chimerix, Inc. (62.94M), greater than Day One Biopharmaceuticals, Inc. (970.79M), greater than X4 Pharmaceuticals, Inc. (49.50M), greater than Mereo BioPharma Group plc (657.97M), greater than Terns Pharmaceuticals, Inc. (770.84M), less than IDEAYA Biosciences, Inc. (2.75B), greater than Syndax Pharmaceuticals, Inc. (1.43B), greater than Xencor, Inc. (1.51B), greater than REGENXBIO Inc. (720.22M), less than Crinetics Pharmaceuticals, Inc. (3.97B), greater than Stoke Therapeutics, Inc. (613.58M), greater than Pliant Therapeutics, Inc. (739.86M), less than Dyne Therapeutics, Inc. (2.87B), less than Cytokinetics, Incorporated (7.18B), less than Revolution Medicines, Inc. (7.17B), less than Blueprint Medicines Corporation (6.34B), greater than Relay Therapeutics, Inc. (1.15B),

Build a custom stock screener for Vericel Corporation (VCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vericel Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vericel Corporation (VCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vericel Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.